Graph theory and network topological metrics may be the potential biomarker in Parkinson's disease

被引:29
|
作者
Huang, Li-Chuan [1 ]
Wu, Ping-An [1 ]
Lin, Shinn-Zong [2 ]
Pang, Cheng-Yoong [3 ,4 ]
Chen, Shin-Yuan [2 ]
机构
[1] Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Med Imaging, Hualien, Taiwan
[2] Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Neurosurg, Hualien, Taiwan
[3] Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Med Res, Hualien, Taiwan
[4] Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Cardiovasc & Metab Res Ctr, Hualien, Taiwan
关键词
Parkinson's disease (PD); Resting-state functional magnetic resonance imaging (rs-fMRI); Functional connectivity (FC); Voxel-based morphometry (VBM); Graph theory; MILD COGNITIVE IMPAIRMENT; FUNCTIONAL CONNECTIVITY; BRAIN NETWORKS; MATTER ATROPHY;
D O I
10.1016/j.jocn.2019.07.082
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This study used Voxel-based morphometry (VBM) and resting-state functional magnetic resonance imaging (rs-fMRI) to investigate changes in brain structure and networks functional connectivity, respectively. We tried to identify the potential biomarkers in Parkinson's disease (PD) progression. We recruited nine idiopathic PD patients and seven healthy control participants (HC group) who were age-matched to undergo T1-weighted images and rs-fMRI on 1.5 T. Brain structure differences were analyzed by VBM. Topological properties of networks functional connectivity were analyzed by graph theory. Thirty-two nodes of 8 networks and 133 nodes of interest then were identified with graph theory approaches. VBM examinations showed significant decreases of brain gray matter regions including the left temporal lobe, left middle temporal, middle temporal gyrus, parietal lobe, postcentral gyrus, left inferior parietal gyrus, medial frontal gyrus and supplement motor area in PD patients compared to the HC group. The 32 ROI of networks topological metrics measurement in PD demonstrated increases of global efficiency, cost, and degree in frontoparietal PPC (R) network, but decreases of local efficiency, clustering coefficient, and average path length in salience ACC, dorsal attention FEF (L), and salience alnsula (R) networks, respectively. All 165 ROI connectomes showed eight connections intensity changes, that decrease in OP r to frontoparietal PPC, putamen r to cereb11, and SFG I to Ver8 in PD. These results suggest that the graph theory and the network topological metrics measurement may be the potential biomarkers in PD to evaluate the disease progress and to monitor the therapeutic results. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页码:235 / 242
页数:8
相关论文
共 50 条
  • [21] Optical Coherence Tomography as Potential Biomarker in Parkinson's Disease and Alzheimer's Disease
    Boeke, Annabel
    Rosen, Darin
    Mastrianni, James
    Xie, Tao
    Bernard, Jacqueline
    NEUROLOGY, 2016, 86
  • [22] Graph theory analysis of dopamine D2 receptor network in Parkinson's disease patients
    Mihaescu, A.
    Kim, J.
    Cho, S.
    Diez-Cirarda, M.
    Valli, M.
    Koshimori, Y.
    Strafella, A.
    MOVEMENT DISORDERS, 2020, 35 : S256 - S256
  • [23] Exosomal microRNAs in Parkinson's disease: insights into biomarker potential and disease pathology
    Chandran, Deepthy
    Krishnan, Syam
    Urulangodi, Madhusoodanan
    Gopala, Srinivas
    NEUROLOGICAL SCIENCES, 2024, 45 (08) : 3625 - 3639
  • [24] Topological alteration of the brain structural network in Parkinson's disease with apathy
    Ge, Shaoyun
    Liu, Jun
    Jia, Yongfeng
    Li, Zihan
    Wang, Jianwei
    Wang, Min
    BRAIN RESEARCH BULLETIN, 2024, 208
  • [25] Brain network activation (BNA): A new biomarker for Parkinson's disease?
    Hassin-Baer, S.
    Pereman, Z.
    Yahav, R.
    Israeli-Korn, S.
    Yahalom, G.
    Benizri, S.
    Shani-Hershkovich, R.
    Issachar, G.
    Geva, A.
    Cohen, O.
    MOVEMENT DISORDERS, 2018, 33 : S693 - S693
  • [26] miR-221 and Parkinson's disease: A biomarker with therapeutic potential
    Zamanian, Mohammad Yasin
    Ivraghi, Mehraveh Sadeghi
    Gupta, Reena
    Prasad, K. D. V.
    Alsaab, Hashem O.
    Hussien, Beneen M.
    Ahmed, Hazem
    Ramadan, Montather F.
    Golmohammadi, Maryam
    Nikbakht, Nikta
    Oz, Tuba
    Kujawska, Malgorzata
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2024, 59 (02) : 283 - 297
  • [27] Phosphorylated α-synuclein as a potential biomarker for Parkinson's disease and related disorders
    Foulds, Penelope
    Mann, David M. A.
    Allsop, David
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2012, 12 (02) : 115 - 117
  • [28] Arylsulfatase A (ASA) in Parkinson's Disease: From Pathogenesis to Biomarker Potential
    Angelopoulou, Efthalia
    Paudel, Yam Nath
    Villa, Chiara
    Piperi, Christina
    BRAIN SCIENCES, 2020, 10 (10) : 1 - 13
  • [29] Ecto-GPR37: a potential biomarker for Parkinson's disease
    Morato, Xavier
    Garcia-Esparcia, Paula
    Argerich, Josep
    Llorens, Franc
    Zerr, Inga
    Paslawski, Wojciech
    Borras, Eva
    Sabido, Eduard
    Petaja-Repo, Ulla E.
    Fernandez-Duenas, Victor
    Ferrer, Isidro
    Svenningsson, Per
    Ciruela, Francisco
    TRANSLATIONAL NEURODEGENERATION, 2021, 10 (01)
  • [30] Complexity of electrocortical activity as potential biomarker in untreated Parkinson's disease
    Mostile, Giovanni
    Giuliano, Loretta
    Dibilio, Valeria
    Luca, Antonina
    Cicero, Calogero Edoardo
    Sofia, Vito
    Nicoletti, Alessandra
    Zappia, Mario
    JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (02) : 167 - 172